| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.41 | 0.006 |